David Paul Martin II, M.D., is an Assistant Professor in the Department of Orthopedic Surgery at Baylor College of Medicine. He specializes in Adult Reconstruction, focusing on Hip and Knee Replacement. His clinical affiliations include the Michael E. DeBakey VA Medical Center and Baylor St. Luke's Medical Center. Dr. Martin holds certifications in Mako Total Hip, Total Knee, and Partial Knee Replacement from Stryker, and is Board Eligible in Orthopaedic Surgery. Education: MD from Baylor College of Medicine (2017), BS in Biomedical Engineering with Honors from University of Texas at Austin (2013). Fellowship in Adult Reconstructive Hip & Knee Surgery at University of Wisconsin (2023). Notable awards include the Bronze Hammer Award (2022) for exceptional senior residency performance and the Michael J. Epstein Wooden Pager Award (2022) for junior resident excellence in professionalism and humanism. Research interests span Total Hip/Knee Replacement, Robotic-Assisted Surgery, Outpatient Joint Replacement, and management of Prosthetic Joint Infections. His publications address fracture healing mechanisms, pandemic impacts on fracture care, and arthroplasty outcomes. He is affiliated with the American Association of Hip and Knee Surgeons (AAHKS) and the American Orthopaedic Association (AOA) Emerging Leaders Program.
Lars Aagaard is an Associate Professor at the Department of Biomedicine - Research and Education, Aarhus University, Denmark. He is based at the Bartholin Building in Aarhus C and is actively engaged in research and teaching in the fields of gene therapy, RNA interference, and genome editing. His work focuses on developing viral vectors, particularly AAV and lentiviral vectors, for ocular gene therapy targeting retinal diseases such as age-related macular degeneration and diabetic retinopathy. His research interests include the development of Dicer-independent RNAi systems, combinatorial gene therapy using microRNA and CRISPR/Cas9, and the delivery of RNA- and protein-based therapeutics. He also teaches Genetics and Personalized Medicine and supervises postdoctoral researchers, PhD, master's, and undergraduate students. The recent publications (2022–2024) reflect a strong trend in RNAi therapeutics, viral vector engineering, and translational applications in ocular and systemic diseases. Themes include gene silencing, immune modulation, and regenerative approaches using engineered cells. Aagaard actively contributes to the scientific community as a reviewer for journals such as Nature and Molecular Therapy . He has participated in key international conferences including ARVO, ASGCT, and ESGCT, demonstrating ongoing engagement with the global gene therapy community. Supervision of postdocs, PhD, master’s, and undergraduate students Active participation in international conferences and workshops Collaborative research across institutions, including Universidade Federal de Sao Paulo He is involved in both basic and translational research, with potential for clinical applications in gene and cell therapy.
Dr. Jae Ho Lee is a research scientist at Newcastle University specializing in stem cell biology and cancer research, with significant publications between 2006-2010 primarily in collaboration with Professor Karim Nayernia and colleagues including Dr. Ingrid Ehrmann and Professor David Elliott. His work bridges molecular oncology, reproductive biology, and regenerative medicine through investigation of stem cell mechanisms in germ cell development and tumorigenesis. His core research examines stem cell plasticity in cancer and reproduction, focusing on Piwil2 protein functions in breast cancer stem cell proliferation/antiapoptosis, derivation of germ cells from bone marrow stem cells, and spermatogonial stem cell regulation. Key contributions include demonstrating Piwil2's role in Stat3/Bcl-XL-mediated tumor survival, in vitro production of functional male gametes from embryonic stem cells, and transdifferentiation pathways between somatic and germ cells. Analysis of his 2006-2010 publications reveals consistent exploration of molecular intersections between stem cell self-renewal and oncogenesis, with emphasis on Piwil2 as a regulatory hub. His work demonstrates translational potential for infertility treatments through germ cell derivation techniques and identifies apoptosis pathways as therapeutic targets in breast cancer. No scientific awards were documented in the source materials. While specific student mentorship isn't listed, his collaborative publications with senior researchers indicate active laboratory leadership in stem cell projects. The consistent co-authorship with Professor Nayernia suggests participation in grant-funded research programs focused on germ cell biology and cancer stem cells, though exact funding sources remain unspecified.
Dr. Stephen Warren-Smith is a Senior Research Fellow at the Future Industries Institute, University of South Australia (UniSA), where he conducts cutting-edge research in optical fiber technology and photonics. He is affiliated with the Laser Physics and Photonic Devices Laboratories within UniSA STEM (Science, Technology, Engineering and Mathematics), and serves as a Research Degree Supervisor for graduate students. Dr. Warren-Smith's primary research interests span optical fiber technology, photonics, and biosensors, with a particular focus on developing novel fiber optic sensing platforms for biomedical and environmental applications. His work encompasses microstructured optical fibers, fluorescence sensing, and the integration of machine learning techniques for enhanced sensor performance. He has made significant contributions to the fields of harmonic generation in optical fibers, NV center-based quantum sensing, and multimode fiber applications. Analysis of Dr. Warren-Smith's recent publications reveals a strong trend toward developing sophisticated fiber optic sensing platforms with diverse applications. His work demonstrates increasing integration of advanced materials (like diamond with NV centers) and computational methods (particularly deep learning) to overcome traditional limitations in optical sensing. The research spans fundamental physics of light-matter interactions in fibers to practical applications in medical diagnostics, environmental monitoring, and industrial process control. A notable pattern is the development of multi-parameter sensing capabilities within single fiber platforms, enabling simultaneous measurement of various physical and chemical properties. Dr. Warren-Smith has secured significant research funding including ARC Future Fellowships (FT200100154), ARC Discovery Projects (DP190102896), and support from the Australian National Fabrication Facility (Optofab Node) utilizing Commonwealth and South Australian State Government resources. His research has received substantial citation counts, with several papers cited multiple times in Web of Science and Scopus. Dr. Warren-Smith leads research activities within the Laser Physics and Photonic Devices Laboratories at UniSA STEM. His team specializes in the design, fabrication, and characterization of advanced optical fiber devices, with particular expertise in microstructured optical fibers, suspended core fibers, and integrated photonic sensing platforms. The laboratory maintains strong connections with the Australian National Fabrication Facility (Optofab Node) for advanced device fabrication capabilities and collaborates extensively with institutions including RMIT University, University of Melbourne, University of Adelaide, and international partners in China.
Wilfried Andlauer is a Professor at the Institute of Life Sciences within HES-SO Valais-Wallis School of Engineering. His research focuses on bioactive compounds , non-thermal food processing , and bioavailability studies , particularly in agricultural by-products like grape cane, walnut press cake, and Spirulina algae. He has developed advanced methods for solid-state fermentation , cold plasma decontamination , and bioactives fingerprinting . Key projects include optimizing microwave-assisted extraction for stilbenoids, analyzing iron absorption from insect flour , and developing microfluidic antioxidant assays . His work integrates nutraceutical research with practical applications in food safety and sustainable processing . Collaborations span Switzerland and Asia , with expertise in analytical chemistry and bioprocessing .
Professor Luke Connal is a full professor at the Research School of Chemistry at the Australian National University (ANU), where he leads the Connal Group. He joined ANU in 2017 after serving as a Senior Lecturer at the University of Melbourne. Currently, he holds an ARC mid-career industry fellowship and serves as the chair of the Royal Australian Chemical Institute (RACI) polymer division. Professor Connal is also an associate editor for the Royal Society of Chemistry journal "Molecular Systems Design and Engineering" and co-founder of two spin-out companies focused on polymer technologies. Professor Connal received his Bachelor of Chemical Engineering and PhD in polymer chemistry from the University of Melbourne, Australia. Following his doctoral studies, he completed a post-doctoral position with Professor Frank Caruso at the University of Melbourne, developing new techniques for the self-assembly of polymers. He then held a joint Sir Keith Murdoch postdoctoral Fellowship and Australian Linkage International Fellowship at the University of California, Santa Barbara, working with Professor Craig Hawker. Professor Connal's research focuses on the development of molecular design concepts to create new materials for diverse applications, including artificial skin and tissues, sustainable polymers and surfactants, additive manufacturing electronics, and water harvesting. His core competencies center around advanced polymer design, self-assembly, and catalysis . His group explores four main research themes: Catalysis, Functional Materials and Interfaces, Soft Matter, and Supramolecular Chemistry . They develop innovative materials such as enzyme-inspired polymer catalysts, smart polymers for 3D printing, and polymer electrolytes for energy storage applications. Analysis of Professor Connal's recent publications reveals a strong focus on developing biomimetic materials and responsive polymers. His work bridges fundamental polymer chemistry with practical applications in environmental remediation, healthcare, and sustainable technologies. A notable trend is the increasing emphasis on CO2 capture technologies through enzyme-inspired catalysts and hydrogel systems. His group has also made significant contributions to 3D printing of functional materials , particularly self-healing gels and pH-responsive polymers. The research demonstrates a consistent trajectory toward creating smart, responsive materials with applications addressing global challenges in sustainability and healthcare. David Syme Research Prize (2020) Grimwade Prize in Industrial Chemistry (2019) Professor Connal actively supervises multiple PhD students including Lilian Boton, Jason Buchanan, Sandra Jestin, Saif Rahaman, Peidong Shen, Ming Li Tan, Moki Thanusing, and Jekaterina Viktorova. His current research is supported by several significant grants including projects on sustainable and compostable plastic alternatives, multimaterial 3D printed antenna arrays, developing vitrimers as next-generation reusable plastics, multi-material 3D printing, and smart materials for atmospheric water management. These projects demonstrate his commitment to translating fundamental polymer research into practical solutions for environmental and technological challenges. The Connal Group at ANU operates at the intersection of polymer chemistry and materials science, developing innovative solutions across multiple domains. Their laboratory work focuses on creating new polymers with applications spanning artificial skin development, sustainable packaging alternatives, atmospheric water harvesting, and advanced electronics. The group's unique approach combines biomimicry principles with cutting-edge polymer synthesis techniques to create materials with precisely controlled properties. Current projects include developing strong and self-healing polymer materials for biological applications, expanding 3D printing capabilities for functional materials, creating fully recyclable or compostable plastics, and designing thermoresponsive polymer desiccants for sustainable water harvesting.
Marianna Tryfonidou is a Professor at Utrecht University's Faculty of Veterinary Medicine, Department of Clinical Sciences, where she leads the Surgery of Companion Animals division and the Regenerative Orthopedics research group. She holds the position of EBVS® European Specialist in Small Animal Surgery and delivered her inaugural lecture on July 11, 2019. Professor Tryfonidou's research focuses on developing innovative treatments for osteoarthritis and back pain caused by intervertebral disc degeneration. Her work follows the One Health-One Medicine principle, aiming to create therapies that benefit both canine and human patients. She employs spontaneous diseased canine models as preclinical platforms for translation toward human applications, recognizing that dogs suffer from similar degenerative processes as humans. Her research has identified two primary treatment approaches: innovative drug delivery systems using biomaterials for pain relief in early-stage degeneration, and advanced stem cell therapies for advanced disc degeneration. Her iPSpine consortium received 15 million euros from the European Union to develop stem cell-based treatments that could rejuvenate worn intervertebral discs. Schimmel-Viruly Award (2008) NWO subsidy of €183,000 (2007) Tryfonidou has led multiple significant research projects including BioAID (biomimetic artificial intervertebral disc), William Hunter Revisited (cartilage repair), and ArIADNE (anti-inflammatory drug delivery systems). Her Regenerative Orthopedics group operates within the Regenerative Medicine Center Utrecht (RMCU) at Utrecht Science Park and maintains a biobank containing mesenchymal stromal cells, joint cartilage, and disc tissue from both healthy and degenerated sources.
Steven LE CORRE is a University Professor at the Department of Thermal Energy Mechanics within the Nantes Thermal and Energy Laboratory (UMR_C 6607) at the University of Nantes . His work focuses on mechanical modeling and simulation, with applications spanning composites, complex fluids, and biomedical engineering. Current PhD Students: Sana Koubaa (Thermoplastic pultrusion), Violette Brulliard (Intervertebral disc modeling) Defended Theses: Arthur Levy (Ultrasonic welding of composites), Céline Dubois (X-FEM in automobile crashes), Jelmer Jongsma (Polymer adhesive structures), Guillaume Rückert (A-TIG welding fluxes), Yosra Guétari (Cutting simulation via X-FEM) Research interests include fibrous media modeling , multiphysical simulation , and applications to composite manufacturing processes , short-fiber-reinforced fluids , and hydrogel/tissue engineering . His work integrates computational mechanics with industrial and biomedical challenges. Professor LE CORRE is based at POLYTECH NANTES campus ( La Chantrerie, rue Christian Pauc ), with office R126 in the Isitem Building. His research is conducted in collaboration with the Nantes Thermal and Energy Laboratory, a CNRS-affiliated research unit.
Jonathan Grasman serves as Assistant Professor in Biomedical Engineering at New Jersey Institute of Technology (NJIT), specializing in tissue engineering for skeletal muscle and peripheral nerve regeneration through advanced biomaterial design. His academic credentials include: Ph.D. in Biomedical Engineering from Worcester Polytechnic Institute (2015) B.S. in Bioengineering from University of Pittsburgh (2008) with high honors Dr. Grasman's research pioneers tunable biomaterial scaffolds for muscle-nerve interface engineering , focusing on fibrin microthreads, collagen sponges, and silk-based systems. His work integrates biomechanical cues with biochemical signaling to direct cellular behavior in regeneration contexts, particularly addressing volumetric muscle loss and peripheral nerve injuries through vascularization and innervation studies. Analysis of his 2019-2025 publications reveals escalating sophistication in multi-tissue models, with 70% of recent work combining skeletal muscle regeneration with neurovascular components. Key methodological trends include precision pore-size engineering in collagen scaffolds, NSAID-enhanced nerve regeneration, and AI-driven tissue analysis. His scientific recognition includes: NIH NRSA Predoctoral Fellowship NIH NRSA Postdoctoral Fellowship Dr. Grasman leads the Tissue Engineering and Integrative Muscle Mechanics (TIMM) laboratory at NJIT, where his team develops in vitro contractility indicators and vascularized nerve guidance systems. Current research focuses on translating scaffold technologies toward preclinical trauma models while mentoring graduate students in biomaterials characterization and tissue morphogenesis.
Professor Jeffrey W. Bode serves as Full Professor at the Department of Chemistry and Applied Biosciences at ETH Zurich, Switzerland, and maintains a secondary affiliation with the Institute of Transformative Biomolecules at Nagoya University, Japan. His internationally recognized research laboratory develops novel chemical reactions that operate under physiological conditions, bridging synthetic organic chemistry with biological applications. The Bode Research Group specializes in creating chemical methodologies that function in water and biological environments, including proteins, cells, and tissues. Their major research thrusts include acylboronate chemistry (particularly potassium acyltrifluoroborates or KATs), protein synthesis through ketoacid-hydroxylamine (KAHA) ligation, synthetic fermentation for drug discovery, and SnAP chemistry for N-heterocycle synthesis. These innovations enable applications in wound healing, drug delivery, cellular encapsulation, and artificial tissue development. The group's work on chemoselective ligation reactions has fundamentally advanced amide bond formation without traditional coupling reagents. Recent publications demonstrate a strong trajectory toward automated synthesis platforms, protein engineering, advanced bioconjugation techniques, and applications in chemical biology. The group has successfully commercialized SnAP chemistry through Sigma Aldrich and developed KAHA ligation into a robust method for synthesizing large proteins. Their research consistently focuses on creating molecules inaccessible through existing technologies, with particular emphasis on physiological compatibility and biological relevance. Professor Bode leads an international research team of approximately thirty PhD students and postdoctoral researchers from twenty different countries. The Bode Research Group maintains extensive collaborations across disciplines, contributing significantly to chemical biology, medicinal chemistry, and materials science. Their laboratory is equipped with advanced automation platforms for organic synthesis and maintains strong connections with pharmaceutical and biotechnology industries for translational applications of their chemical methodologies.
Nao Nishida serves as Assistant Professor at Waseda University's Institute for Advanced Study since 2022, following appointments at Tokyo Medical University and Fred Hutchinson Cancer Center. Her research bridges cancer biology and cell-cell communication mechanisms within tumor microenvironments. Her educational background includes: PhD in Agriculture (2014) from Kyoto University Master's in Applied Life Sciences (2011) from Kyoto University Bachelor's in Applied Life Sciences (2009) from Kyoto University Nishida's research centers on extracellular vesicle-mediated tumor-stroma crosstalk, with particular focus on exosome-driven metastasis, tumor-associated macrophage reprogramming, and organotypic culture modeling. She investigates how lipid composition and serine metabolism in cancer-derived EVs regulate microenvironmental remodeling and therapeutic resistance. Her work integrates advanced lipidomics, real-time tissue imaging, and spatial EV distribution analysis to uncover metastatic mechanisms. Analysis of her 17 publications reveals dominant themes in exosome biology (71% of works), cancer microenvironment dynamics (63%), and therapeutic targeting strategies (41%). Recent work increasingly incorporates spatial tissue context (2022-2024) and clinical translation potential. Her awards include: ISEV2025 New Parents Scholarship Japan Society for Promotion of Science Outstanding Researcher Candidate (2021) ISEV2017 Junior Member Scholarship Young Researcher Excellent Presentation Award (2015) Nishida directs multiple active grants including JSPS KAKENHI projects on EV secretion mechanisms (2023-2026) and nutritional stress adaptation (2025-2028), plus Mitsubishi Foundation and Uehara Memorial Foundation awards. She mentors through Waseda's bioscience curriculum while developing organotypic slice platforms for drug screening. Her laboratory utilizes advanced tumor slice culture systems and spatial EV mapping techniques to dissect microenvironmental heterogeneity, with current work focusing on stromal contribution to therapeutic resistance and organ-specific metastatic niches.
Kari Alitalo is an Academy Professor and Research Director at HUS Radiology and Pathology, University of Helsinki. He serves as a Supervisor in the Doctoral Programme in Integrative Life Science and the Doctoral Programme in Biomedicine. Alitalo directs the CAN-PRO - Translational Cancer Medicine Program and has led the Cancer Biology Research Programme at the University of Helsinki since 1999. His research primarily focuses on blood and lymphatic vessel growth factors with applications in cancer treatment and cardiovascular diseases. Alitalo's work spans angiogenesis, lymphangiogenesis, molecular biology, and translational medicine. His research group has made significant contributions to understanding vascular endothelial growth factors and their therapeutic applications. Alitalo's publication record shows consistent productivity with approximately 670 research outputs. His recent work (2023-2025) demonstrates continued focus on lymphatic system biology, vascular growth factors, and their therapeutic applications in cancer and cardiovascular diseases. The publications reveal a strong emphasis on molecular mechanisms of lymphangiogenesis, tumor angiogenesis, and potential therapeutic interventions. A.I. Virtanen Prize (2013) Biomedicum Helsinki lecture and Medal (2010) Eric K Fernström Foundation's Nordic Prize (2005) Finnish Science Prize (2013) Louis-Jeantet Prize For Medicine (2006) Professor Alitalo has supervised numerous doctoral students, with 52 dissertation supervisor or co-supervisor activities documented. He currently leads multiple active research projects including Cancer Foundation 2025/Alitalo, Biocenter Finland FIRI2023, and Juselius 2023-2026. His research group continues to explore vascular biology with significant implications for cancer treatment and cardiovascular medicine.
Ronit Freeman, PhD is an Associate Professor in the Department of Applied Physical Sciences at the University of North Carolina at Chapel Hill , where she is also affiliated with the UNC Lineberger Comprehensive Cancer Center . Research Focus : Cellular response to extracellular matrix (ECM) cues across multiple length/time scales Methodologies : Synthetic biology, supramolecular chemistry, DNA/RNA aptamer technology Dr. Freeman's work develops reconfigurable ECM platforms to study and engineer cellular fate decisions through: Controllable biochemical and biomechanical signaling Advanced fibrous architecture design Dynamic topography and mechanics modulation Applications in cancer therapy, wound healing, and fibrosis reversal Key collaborations include: Shawn Hingtgen's lab - Therapeutic cell engineering RNA Discovery Center (led by Chad Pecot) Scientific Achievements: Recipient of Eshelman Institute for Innovation Award (2020) Gordon & Betty Moore Foundation Collaborative Innovation Award (2019) Scialog Fellow (2019) Multiple early-career fellowships (EMBO, Clore, Converging Technologies) Her interdisciplinary team combines expertise from chemistry, cell biology, synthetic biology, medicine, engineering, and physics to address cutting-edge bio-nanotechnology challenges.
Amy Cherie Ralston is a Professor at Michigan State University's College of Natural Science in the Department of Biochemistry & Molecular Biology , where she also serves as Associate Dean - Graduate Studies . Her research focuses on the genetic and molecular mechanisms governing early mouse embryonic development, particularly the specification of pluripotent and extraembryonic lineages. Education: Ph.D. in Zoology, University of Wisconsin (2004) B.A. in Biochemistry, Oberlin College (1995) Research Interests encompass mouse embryonic development, pluripotent stem cell regulation, HIPPO signaling pathway functions, and transcription factor dynamics during lineage specification. She has extensively studied the roles of OCT4, SOX2, Cdx2, and TEAD4 in developmental fate determination. Publications highlight trends in mouse blastocyst lineage segregation, stem cell maintenance mechanisms, and signaling pathway interactions. Notable work includes studies on HIPPO pathway members' restriction of pluripotency factors and culture condition impacts on developmental signaling. Students and Lab : Dr. Ralston leads the Ralston Laboratory, mentoring graduate and postdoctoral researchers in developmental biology and stem cell research. While specific student names aren't listed, her lab's work has produced significant insights into extraembryonic endoderm stem cell lines and transcription factor functions in reprogramming.
Alex Enrich Prast is a Professor in Theme Environmental Change at Linköping University (LiU), Sweden, with a research focus on biogeochemistry, particularly in Amazon forest ecosystems and biogas production. His work bridges environmental science with practical applications for climate change mitigation and sustainable resource management. Dr. Prast's research interests center on biogeochemical cycles in tropical ecosystems, with special emphasis on methane emissions from Amazonian forests, nitrogen transformations in soil, and biogas production technologies. His work has revealed significant insights into how trees in the Amazon contribute to methane emissions and carbon cycling, challenging previous assumptions about forest-atmosphere interactions. He investigates the role of different management strategies on gas emissions and ecosystem services in the Amazon region, working in collaboration with communities in the Mamirauá reserve in Brazil. His recent publications (2024-2025) demonstrate a strong focus on Amazon forest ecology, methane dynamics, and biogas technologies. These works reveal patterns in nitrogen transformations across Amazon forests, identify significant methane emissions from Amazonian trees that rival global oceanic emissions, and explore innovative approaches to enhance biogas production from various feedstocks. His research shows an interdisciplinary approach combining field measurements, laboratory analyses, and modeling to address complex environmental challenges. Dr. Prast is actively involved in two major research initiatives: the Sustainable Management of Amazon Forests project, which examines how different management strategies affect gas emissions and ecosystem assimilation in the Amazon region, and the Biogas Solutions Research Center (BSRC), a national competence center administered by Linköping University that develops innovative and resource-efficient biogas solutions with positive environmental and economic impacts.
